Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its proprietary drug discovery platform. This platform enables the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix’ value creation strategy is built around developing an internal pipeline of drug candidates and partnerships with the leading biopharmaceutical companies. Ribometrix is backed by a syndicate of blue-chip venture investors. 

Information Technology

Ribometrix

Allen Zhang

Katie Warner

Jessica Sorrentino

Orshi Kocsis

Jonathan Kearns

Murty Changalvala

Ramamurty Changalvala

Kevin Weeks

Research and Development

Leadership Team

Finance and Accounting

Teams at Ribometrix

Research and Development

Leadership Team

Finance and Accounting